V. Aimola, D. Fanni, C. Gerosa, G. Cerrone, P. Ziranu, A. Pretta, R. Murru, M. Piras, F. Cau, L. Zorcolo, G. La Nasa, M. Castagnola, M. Scartozzi, G. Faa
{"title":"干细胞标志物CD44和CDX2在结直肠癌中的表达平衡","authors":"V. Aimola, D. Fanni, C. Gerosa, G. Cerrone, P. Ziranu, A. Pretta, R. Murru, M. Piras, F. Cau, L. Zorcolo, G. La Nasa, M. Castagnola, M. Scartozzi, G. Faa","doi":"10.48286/aro.2022.43","DOIUrl":null,"url":null,"abstract":"CDX2 (Caudal-type homeobox transcription factor 2) is a biomarker of differentiated colon enterocytes, whose expression has been associated with a favora-ble prognosis in colon cancer. The absence of CDX2 has been associated with an","PeriodicalId":148778,"journal":{"name":"Annals of Research in Oncology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer\",\"authors\":\"V. Aimola, D. Fanni, C. Gerosa, G. Cerrone, P. Ziranu, A. Pretta, R. Murru, M. Piras, F. Cau, L. Zorcolo, G. La Nasa, M. Castagnola, M. Scartozzi, G. Faa\",\"doi\":\"10.48286/aro.2022.43\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"CDX2 (Caudal-type homeobox transcription factor 2) is a biomarker of differentiated colon enterocytes, whose expression has been associated with a favora-ble prognosis in colon cancer. The absence of CDX2 has been associated with an\",\"PeriodicalId\":148778,\"journal\":{\"name\":\"Annals of Research in Oncology\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Research in Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.48286/aro.2022.43\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Research in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48286/aro.2022.43","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Balance between the stem cell marker CD44 and CDX2 expression in colorectal cancer
CDX2 (Caudal-type homeobox transcription factor 2) is a biomarker of differentiated colon enterocytes, whose expression has been associated with a favora-ble prognosis in colon cancer. The absence of CDX2 has been associated with an